Details for New Drug Application (NDA): 020708
✉ Email this page to a colleague
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 020708
Tradename: | LUPRON DEPOT |
Applicant: | Abbvie Endocrine Inc |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020708
Suppliers and Packaging for NDA: 020708
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708 | NDA | AbbVie Inc. | 0074-3663 | 0074-3663-03 | 1 KIT in 1 CARTON (0074-3663-03) * 1.5 mL in 1 SYRINGE * 1 mL in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 11.25MG | ||||
Approval Date: | Mar 7, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020708
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription